Cargando…
Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics
Autores principales: | Chandrasekaran, Balakumar, Saravanan, Muthupandian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280165/ https://www.ncbi.nlm.nih.gov/pubmed/37346302 http://dx.doi.org/10.3389/fphar.2023.1229673 |
Ejemplares similares
-
Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I
por: Chandrasekaran, Balakumar, et al.
Publicado: (2022) -
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
por: Jain, Nem Kumar, et al.
Publicado: (2023) -
Editorial: Anti-cancer bioactive molecules from microbial sources
por: Mishra, Bishwambhar, et al.
Publicado: (2023) -
Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives
por: Vivekanandhan, Karthik, et al.
Publicado: (2021) -
Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19
por: Naik, Rajashri R., et al.
Publicado: (2022)